drugset / Trial / NCT01993160
18F-FCH (Fluorocholine)-PET/MR in Staging of High-Risk Prostate Cancer
NaSingle-groupOpen-labelDiagnostic
Summary
This is a single centre, single arm feasibility study of 18FCH PET-MR imaging for staging patients with high risk prostate cancer. Study Hypothesis: FCH-PET/MR will enable more accurate staging of patients with high risk prostate cancer as compared to conventional imaging.
Timeline
- Start
- 2013-12
- Primary completion
- 2016-12
- Completion
- 2016-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | fluorocholine | Diagnostic / imaging agent | — | Intravenous |